Trials / Completed
CompletedNCT05416034
Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy
Study of the Impact of a Gait Exoskeleton on the Quality of Life of Patients With Spinal Muscular Atrophy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- MarsiBionics · Industry
- Sex
- All
- Age
- 4 Years – 9 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the impact of the use of a pediatric exoskeleton on the quality of life of children, specifically in the psychological and care dimensions. Other objectives are to evaluate changes at the physical and functional level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Use of the ATLAS 2025 exoskeleton at home | Each participant will use the ATLAS 2025 exoskeleton at their homes, 5 days a week during a period of two months, for walking with the device and performing motor activities in 60 minutes duration sessions.. |
Timeline
- Start date
- 2017-12-01
- Primary completion
- 2018-07-30
- Completion
- 2018-08-31
- First posted
- 2022-06-13
- Last updated
- 2022-06-13
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05416034. Inclusion in this directory is not an endorsement.